MAM
USNA icon

Martingale Asset Management’s Usana Health Sciences USNA Stock Holding History

Martingale Asset Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,054
Closed -$525K – 847
2025
Q3 		$525K Buy
19,054
+120
+0.6% +$3.69K 0.01% 607
2025
Q2 		$578K Buy
18,934
+1,392
+8% +$39.5K 0.01% 590
2025
Q1 		$473K Buy
17,542
+900
+5% +$28.5K 0.01% 607
2024
Q4 		$597K Sell
16,642
-90
-0.5% -$3.37K 0.01% 573
2024
Q3 		$634K Buy
16,732
+340
+2% +$14K 0.01% 575
2024
Q2 		$742K Buy
16,392
+1,202
+8% +$55.3K 0.02% 518
2024
Q1 		$737K Buy
15,190
+500
+3% +$24.5K 0.01% 533
2023
Q4 		$787K Buy
14,690
+483
+3% +$24.4K 0.02% 505
2023
Q3 		$833K Buy
14,207
+1
+0% +$63 0.02% 488
2023
Q2 		$896K Buy
14,206
+7
+0% +$446 0.02% 475
2023
Q1 		$893K Buy
14,199
+100
+0.7% +$5.97K 0.02% 474
2022
Q4 		$750K Buy
14,099
+650
+5% +$35.2K 0.01% 541
2022
Q3 		$755K Buy
13,449
+57
+0.4% +$3.77K 0.02% 520
2022
Q2 		$970K Buy
13,392
+807
+6% +$60.1K 0.02% 476
2022
Q1 		$1M Buy
12,585
+100
+0.8% +$9.02K 0.02% 482
2021
Q4 		$1.26M Sell
12,485
-300
-2% -$29.9K 0.02% 426
2021
Q3 		$1.18M Buy
12,785
+7,480
+141% +$720K 0.02% 473
2021
Q2 		$544K Sell
5,305
-100
-2% -$10K 0.01% 561
2021
Q1 		$529K Sell
5,405
-300
-5% -$27.3K 0.01% 592
2020
Q4 		$441K Sell
5,705
-24,301
-81% -$1.88M 0.01% 649
2020
Q3 		$2.21M Sell
30,006
-16,500
-35% -$1.32M 0.03% 387
2020
Q2 		$3.42M Buy
46,506
+37,303
+405% +$2.93M 0.04% 391
2020
Q1 		$532K Sell
9,203
-9,603
-51% -$668K 0.01% 802
2019
Q4 		$1.48M Buy
18,806
+400
+2% +$29.5K 0.02% 673
2019
Q3 		$1.26M Sell
18,406
-25,704
-58% -$1.73M 0.01% 714
2019
Q2 		$3.5M Sell
44,110
-10,505
-19% -$833K 0.04% 464
2019
Q1 		$4.58M Buy
54,615
+7,300
+15% +$762K 0.05% 386
2018
Q4 		$5.57M Buy
47,315
+13,103
+38% +$1.52M 0.07% 288
2018
Q3 		$4.13M Sell
34,212
-1,704
-5% -$211K 0.05% 367
2018
Q2 		$4.14M Sell
35,916
-1
-0% -$109 0.05% 359
2018
Q1 		$3.09M Buy
35,917
+1,000
+3% +$77.4K 0.04% 419
2017
Q4 		$2.59M Sell
34,917
-2,598
-7% -$174K 0.03% 457
2017
Q3 		$2.17M Buy
37,515
+699
+2% +$41.3K 0.03% 539
2017
Q2 		$2.36M Buy
36,816
+1
+0% +$62 0.03% 509
2017
Q1 		$2.12M Hold
36,815
– – 0.03% 531
2016
Q4 		$2.25M Buy
36,815
+1,859
+5% +$121K 0.03% 512
2016
Q3 		$2.42M Buy
34,956
+27,600
+375% +$1.82M 0.04% 467
2016
Q2 		$410K Buy
7,356
+160
+2% +$9.65K 0.01% 703
2016
Q1 		$437K Buy
7,196
+1,400
+24% +$82.4K 0.01% 677
2015
Q4 		$371K Sell
5,796
-100
-2% -$6.49K 0.01% 717
2015
Q3 		$396K Sell
5,896
-4,520
-43% -$320K 0.01% 692
2015
Q2 		$712K Sell
10,416
-904
-8% -$57.4K 0.02% 611
2015
Q1 		$629K Sell
11,320
-200
-2% -$10.3K 0.02% 657
2014
Q4 		$591K Sell
11,520
-902
-7% -$44.3K 0.02% 657
2014
Q3 		$458K Hold
12,422
– – 0.01% 688
2014
Q2 		$486K Sell
12,422
-400
-3% -$14.8K 0.02% 693
2014
Q1 		$484K Buy
12,822
+1,002
+8% +$35K 0.02% 684
2013
Q4 		$447K Buy
11,820
+796
+7% +$30.5K 0.02% 800
2013
Q3 		$479K Hold
11,024
– – 0.02% 761
2013
Q2 		$399K Buy
+11,024
New +$335K 0.01% 793

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Martingale Asset Management's USNA Position: Q4 2025 in Review

Martingale Asset Management sold out of Usana Health Sciences (USNA) in Q4 2025, closing a stake of 19,054 shares — an estimated $525K sold.

Martingale Asset Management first reported a position in USNA in Q2 2013 and held it in 50 quarters. The position peaked at $5.57M in Q4 2018. 121 funds tracked by Wall St. Rank hold USNA as of Q4 2025.

  • Martingale Asset Management reported no remaining Usana Health Sciences position as of Q4 2025 after selling out during the quarter.
  • Martingale Asset Management sold 19,054 Usana Health Sciences shares in Q4 2025, an estimated $525K.
  • Martingale Asset Management first reported a position in Usana Health Sciences in Q2 2013 and held it in 50 quarters.
  • Martingale Asset Management's Usana Health Sciences position peaked at $5.57M in Q4 2018.
  • 121 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2025.

Based on Martingale Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.